Investors and PArtners

---

The Isotech system uses unique technology to address a critical healthcare challenge which costs insurers and healthcare systems billions annually.  

There is no real competition for the device and it  solves a problem which can save huge amounts of money and improve patients lives immeasurably. With an ageing population, our device presents an unparalleled opportunity for investors to be part of a transformative technology company.

The ISO-101 device is being clinical validated, demonstrated its effectiveness in a clinical scenario. Our device has received positive feedback from leading healthcare professionals, reinforcing its potential to redefine standards of care in postural hypotension.

Isotech has a very strong team of board members and advisors with experience of developing and launching medical devices and growing companies, thus reducing risk and maximizing potential returns for investors.

The Isotech system is on track to meet and exceed regulatory standards. Our dedicated team is actively engaged with regulatory authorities to navigate the approval process efficiently, ensuring a swift market entry.